Meglitinide analogues for type 2 diabetes mellitus
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The aim of this review is to assess the effects of meglitinide analogues in patients with type 2 diabetes mellitus, as single therapy, in combination with other oral hypoglycaemic agents, and in combination with insulin.